/

Epic Bio

Develops CRISPR-based epigenetic therapies for treating genetic diseases.

BiotechnologyHealthcare epic-bio.com ↗

Company facts

Founded: 2018
Employees: 50
Headquarters: United States
Type: Private
Funding: Series B · $68M · 2025